# Gate 3: Post-Tier 3 Reasoning Checkpoint - Standard Chartered

**Bank:** Standard Chartered
**Phase:** 6 (Deep Dive)
**Date:** 2025-12-21

---

## Current State

**Provisional Classification:** ARCHITECT (Leader)
**Provisional Confidence:** 80%
**Evidence Collected:** 4 Tier 1 + 1 Tier 2 + 0 Tier 3 = 5 total items

---

## Tier 3 Search Summary

**Searches Conducted:**
1. LinkedIn job postings: "CDM" + "Standard Chartered"
2. Medium/blog articles: "Standard Chartered CDM implementation"
3. Regional news: "Standard Chartered derivatives technology Asia"

**Results:** No relevant Tier 3 evidence found.

---

## Gate 3 Criteria

### 1. Informative Absence Analysis

**Question:** What does the absence of Tier 3 evidence tell us?

**Interpretation:**

**No Job Posting Signals:**
- **Possible Explanation 1:** Implementation complete, no active hiring for CDM roles
- **Possible Explanation 2:** CDM skills developed internally via training
- **Possible Explanation 3:** Vendor-managed implementation (no internal hiring needed)
- **Impact:** Neutral to slightly positive (no evidence of hiring struggles)

**No LinkedIn/Blog Activity:**
- **Possible Explanation 1:** Non-disclosure culture (common in Asian banks)
- **Possible Explanation 2:** Competitive sensitivity (don't advertise technical advantage)
- **Possible Explanation 3:** Project stalled or discontinued (no one promoting it)
- **Impact:** Neutral (consistent with Standard Chartered's low social media profile)

**No Regional Press Coverage:**
- **Possible Explanation 1:** Asia-Pacific media less focused on technical standards
- **Possible Explanation 2:** European implementation only (not Asia-Pacific)
- **Possible Explanation 3:** Standard Chartered's Asia focus means less Western press coverage
- **Impact:** Neutral to slightly negative (could indicate regional limitation)

**Verdict:** Informative absence is **NEUTRAL** overall, neither strongly supporting nor undermining ARCHITECT classification.

---

### 2. Evidence Sufficiency

**Question:** Is the existing evidence base sufficient to support final classification without Tier 3?

**Evidence Summary:**
- **Tier 1:** 4 items (production_usage × 2, membership_or_participation × 2)
- **Tier 2:** 1 item (membership_or_participation)
- **Tier 3:** 0 items

**Sufficiency Analysis:**
- ✅ Multiple Tier 1 production usage claims (meets ARCHITECT threshold)
- ✅ Technical and governance signals (demonstrates depth)
- ✅ Tier 2 corroboration (senior technical leader)
- ⚠️ Source concentration (all ISDA)
- ⚠️ Temporal staleness (no 2025 evidence)
- ⚠️ Production scope ambiguity (no scale metrics)

**Per CLAUDE.md Section 7:**
- Tier 1 evidence cap: 95% confidence
- Multiple Tier 1 sources: Supports high confidence
- Source diversity limitation: Justifies <90% confidence

**Verdict:** Evidence base is **SUFFICIENT** for 80% confidence ARCHITECT classification, even without Tier 3.

---

### 3. Final Confidence Calibration

**Starting Point:** 80% (from Tier 2)

**Tier 3 Absence Impact:**

**No Adjustment Needed:**
- Absence of Tier 3 evidence is neutral (not negative)
- Tier 1 and Tier 2 evidence base already strong
- 80% confidence already accounts for evidence limitations

**Alternative Interpretation:**
If we interpreted absence as negative signal (possible discontinuation):
- −5% for no recent hiring signals
- −5% for no community engagement
- Would reduce to 70% confidence

**Decision:** Maintain 80% confidence based on neutral interpretation of Tier 3 absence.

---

### 4. Classification Stability Test

**Question:** Would any reasonably likely new evidence change the classification?

**Scenario Analysis:**

**Evidence That Would Increase Confidence to 90%:**
- Recent (2025) trade press article confirming production usage
- Standard Chartered annual report mentioning CDM
- Regulatory filing confirming CDM-based reporting
- Vendor case study with scale metrics

**Evidence That Would Decrease Confidence to 60-70%:**
- Vendor announcement claiming Standard Chartered as client (suggests PRAGMATIST)
- News of CDM program discontinuation
- Evidence of pilot-only scope (not true production)
- Staff departures (key CDM leaders leaving)

**Evidence That Would Change Classification:**
- Definitive proof of vendor-only implementation → PRAGMATIST (Vendor)
- Proof of discontinued program → OBSERVER or UNKNOWN
- Proof of pilot-only → PRAGMATIST or OBSERVER

**Likelihood of Classification Change:** 20-25% (per pre-mortem vendor dependency scenario)

**Verdict:** Classification is **STABLE** but not bulletproof. 80% confidence appropriate.

---

### 5. Adversarial Review Readiness

**Question:** Is the evidence base ready for adversarial stress-testing?

**Readiness Checklist:**
- ✅ Clear classification (ARCHITECT Leader at 80%)
- ✅ Documented evidence trail (5 items)
- ✅ Identified risk factors (source concentration, temporal staleness, production scope)
- ✅ Alternative hypotheses defined (PRAGMATIST at 15%, Pilot at 15%)
- ✅ Pre-mortem completed (failure scenarios identified)

**Outstanding Questions for Adversarial Review:**
1. Is "production usage" claim definitively proven or potentially pilot/POC?
2. Does absence of GitHub activity indicate vendor dependency?
3. Why no trade press coverage for a Tier 1 bank CDM implementation?
4. Is evidence staleness (no 2025 updates) a red flag for discontinuation?
5. Are we over-weighting ISDA sources due to confirmation bias?

**Verdict:** Evidence base is **READY** for adversarial review. All risk factors identified and documented.

---

### 6. Final Evidence Quality Score

| Dimension | Score | Max | Notes |
|-----------|-------|-----|-------|
| Authority (Tier 1 dominance) | 9 | 10 | Strong Tier 1 base |
| Recency (temporal freshness) | 5 | 10 | All evidence >12 months old |
| Diversity (source independence) | 4 | 10 | All ISDA sources |
| Specificity (production details) | 6 | 10 | Vague on scale/scope |
| Corroboration (multiple sources) | 7 | 10 | 5 sources, but same ecosystem |
| Completeness (search exhaustiveness) | 7 | 10 | Tier 1-3 searched, regulators not |

**Total Quality Score:** 38/60 (63%)

**Interpretation:** Evidence quality is **GOOD** but not excellent. 80% confidence is well-calibrated to quality score.

---

## Gate 3 Decision Matrix

| Criterion | Status | Weight | Score |
|-----------|--------|--------|-------|
| Informative Absence Analysis | NEUTRAL | 15% | 8/15 |
| Evidence Sufficiency | SUFFICIENT | 25% | 20/25 |
| Confidence Calibration | STABLE at 80% | 20% | 18/20 |
| Classification Stability | STABLE (20% risk) | 15% | 12/15 |
| Adversarial Readiness | READY | 15% | 15/15 |
| Evidence Quality Score | GOOD (63%) | 10% | 6/10 |

**Total Score:** 79/100

---

## Gate 3 Verdict

**Decision:** ✅ PROCEED TO ADVERSARIAL REVIEW

**Final Classification (Pre-Adversarial):**
- **Classification:** ARCHITECT (Leader)
- **Confidence:** 80%
- **Maturity Score:** 5

**Confidence Breakdown:**
- Base posterior (Bayesian): 90.9%
- Source concentration penalty: −5%
- Temporal staleness penalty: −5%
- Production scope ambiguity: −0.9%
- **Final:** 80%

**Key Strengths:**
1. Multiple Tier 1 production usage claims
2. Technical depth (senior analytics leader)
3. Governance engagement (ISDA Board)
4. No contradictory evidence

**Key Weaknesses:**
1. Source concentration (all ISDA)
2. Temporal staleness (no 2025 evidence)
3. Production scope ambiguity (no scale metrics)
4. Absence of independent corroboration

**Risk Factors for Adversarial Review:**
1. **Vendor Dependency Risk:** 25% (per pre-mortem)
2. **Pilot vs. Production Risk:** 15%
3. **Regional Scope Risk:** 20%
4. **Discontinuation Risk:** 15%
5. **Governance-Only Risk:** 10%

---

## Proceed to Adversarial Review

**Gate Status:** ✅ OPEN

**Next Stage:** Adversarial Review (Counter-Case → Steelman → Verdict)

**Mandate for Adversarial Review:**
Stress-test the ARCHITECT classification against the top 3 risk factors:
1. Vendor dependency misclassified as native capability
2. Regional implementation (Europe only) misclassified as bank-wide
3. Evidence staleness indicating possible discontinuation

**Target Outcome:** Confirm 80% confidence or adjust to 70-75% based on adversarial findings.
